CABOTRES Tablets 20 MG 1 x 30'S

Form: Tablet

Pack Size: 30 Tablets

Marketed by: CIPLA LTD (CANCER CARE)

MRP: ₹8765.62

Cabotres 20mg by Cipla (cabozantinib 20 mg, 30 tablets) is a multi-kinase inhibitor (targeted therapy) listed under Cancer Care (Oncology) on WholesaleChemist for distributors, hospital pharmacies and retail chemists. Prescribed by oncologists for advanced kidney cancer, liver cancer previously treated with sorafenib and differentiated thyroid cancer that has progressed after earlier treatment. Schedule H: dispense only against a valid prescription. Counselling point: watch for hand-foot syndrome and hypertension; withhold before surgery.

Available at wholesale price for chemists, retailers and distributors on WholesaleChemist.